Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Oct 12, 2021 $30.12 $31.72 $30.12 $31.37 872 570
Oct 11, 2021 $29.62 $30.89 $29.16 $30.30 889 189
Oct 08, 2021 $27.76 $29.67 $27.42 $29.60 1 427 925
Oct 07, 2021 $26.71 $28.35 $26.28 $27.81 1 796 250
Oct 06, 2021 $25.76 $26.21 $25.26 $25.41 1 371 601
Oct 05, 2021 $26.09 $26.64 $25.28 $25.81 1 221 236
Oct 04, 2021 $26.04 $26.48 $25.30 $26.12 1 049 133
Oct 01, 2021 $25.36 $26.42 $25.11 $26.25 857 586
Sep 30, 2021 $26.03 $26.03 $25.21 $25.48 720 245
Sep 29, 2021 $26.49 $27.05 $25.60 $25.80 738 355
Sep 28, 2021 $26.18 $27.39 $26.10 $26.55 1 115 963
Sep 27, 2021 $25.63 $26.34 $25.35 $26.22 3 913 626
Sep 24, 2021 $26.39 $26.75 $25.51 $25.57 937 104
Sep 23, 2021 $26.30 $26.77 $25.99 $26.52 1 539 495
Sep 22, 2021 $26.90 $26.90 $26.10 $26.14 926 621
Sep 21, 2021 $27.27 $28.23 $26.93 $27.00 792 415
Sep 20, 2021 $27.31 $27.89 $26.56 $27.10 1 173 545
Sep 17, 2021 $26.51 $28.22 $26.01 $28.03 2 417 747
Sep 16, 2021 $26.00 $26.39 $25.77 $26.35 884 710
Sep 15, 2021 $26.16 $27.17 $25.93 $25.97 1 003 693
Sep 14, 2021 $27.48 $27.99 $26.21 $26.29 1 084 512
Sep 13, 2021 $28.01 $28.14 $27.01 $27.30 1 790 793
Sep 10, 2021 $30.34 $30.34 $28.09 $28.11 840 387
Sep 09, 2021 $29.94 $30.83 $29.70 $30.12 1 381 094
Sep 08, 2021 $29.60 $30.38 $29.52 $30.00 1 128 551
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT